SymBiosis Capital Partners, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Rani Therapeutics Holdings, Inc. 13G/A Amendment 1
0753018100
4.4% 5/15/2026
Event 3/27/2026
Rani Therapeutics Holdings, Inc. 13G
0753018100
6.5% 2/12/2026
Event 11/13/2025
Generation Bio Co. 13G/A Amendment 1
GBIO · 37148K209
6.3% 11/14/2025
Event 9/30/2025
Generation Bio Co. 13G
GBIO · 37148K209
6.3% 11/14/2025
Event 9/30/2025